ContactUs

Head Office

Head Office

5575 North Service Road,
Suite 603
Burlington, ON, L7L 6M1
Canada

CurrentNews

EmpowerPharm Inc. is delighted to announce the outcome of their Phase 2 clinical trial assessing Cannabidiol (CBD) drug product for Social Anxiety Disorder (SAD)

EmpowerPharm Inc. https://empowerpharm.ca/ is delighted to announce the outcome of their Phase 2 clinical trial assessing the dose finding, efficacy, safety, and tolerability of Cannabidiol ...
Read More →

EMPOWERPHARM AWAITS PHASE II CLINICAL TRIAL ON GROUND BREAKING TREATMENT TO MANAGE SOCIAL ANXIETY DISORDER

Burlington, ON March 11, 2024 - EmpowerPharm Inc. is delighted to announce that the final participant has completed their treatment in the Phase II clinical ...
Read More →

EmpowerPharm Patent- PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION OF CANNABINOIDS was published today.

EmpowerPharm® a clinical stage pharmaceutical company specializing in cannabinoid-based drug development of prescription products. These products target therapeutic indications where ...
Read More →

Subscribe to get the latest news.